DAWN (Day One Biopharmaceuticals) Accounts Payable: $3.7 Mil (As of Dec. 2025)


DAWN Day One Biopharmaceuticals Inc DAWN
12 GF Score
Price $21.53
! 5 Warning Signs
View Full Analysis

What is Day One Biopharmaceuticals Accounts Payable?

Day One Biopharmaceuticals DAWN 12 Accounts Payable is $3.7 Mil as of Dec. 2025. GuruFocus rates DAWN with a GF Score™ of 12/100. The stock has 5 warning signs investors should review.

Day One Biopharmaceuticals's Accounts Payable for the quarter that ended in Dec. 2025 was $3.7 Mil.

Day One Biopharmaceuticals's quarterly Accounts Payable increased from Jun. 2025 ($5.1 Mil) to Sep. 2025 ($5.8 Mil) but then declined from Sep. 2025 ($5.8 Mil) to Dec. 2025 ($3.7 Mil).

Day One Biopharmaceuticals's annual Accounts Payable increased from Dec. 2023 ($2.6 Mil) to Dec. 2024 ($3.3 Mil) and increased from Dec. 2024 ($3.3 Mil) to Dec. 2025 ($3.7 Mil).

Day One Biopharmaceuticals Accounts Payable Related Terms

Day One Biopharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Day One Biopharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Day One Biopharmaceuticals Accounts Payable Chart

Day One Biopharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 1.74 0.26 2.58 3.26 3.73

Day One Biopharmaceuticals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.26 2.54 5.09 5.78 3.73
DAWN
12GF Score
Day One Biopharmaceuticals Inc DAWN
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Day One Biopharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $3.7 Mil mean?
Day One Biopharmaceuticals (DAWN) has a Accounts Payable of $3.7 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Day One Biopharmaceuticals and its competitors.
Is Day One Biopharmaceuticals' Accounts Payable too high?
Day One Biopharmaceuticals' current Accounts Payable is $3.7 Mil. Overall, Day One Biopharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Day One Biopharmaceuticals' Accounts Payable compare to TYRA and DFTX?
Day One Biopharmaceuticals' Accounts Payable of $3.7 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Day One Biopharmaceuticals and its competitors. Day One Biopharmaceuticals's current Accounts Payable is $3.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Day One Biopharmaceuticals stock overvalued right now?
Day One Biopharmaceuticals (DAWN) has a current Accounts Payable of $3.7 Mil. The current Accounts Payable is $3.7 Mil. Day One Biopharmaceuticals' overall GF Score™ is 12/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Day One Biopharmaceuticals (DAWN), the current Accounts Payable is $3.7 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Day One Biopharmaceuticals Business Description

Address 1800 Sierra Point Parkway, Suite 200, Brisbane, CA, USA, 94005
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.
12GF Score

Get the complete analysis for DAWN

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.53
Price